EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antidepressants Use Among Pregnant Women in Denmark From 2001 to 2023: A Population‐Level Drug Utilization Study

Anne-Johanne Andersen iD, Kasper Nørlund Enevoldsen, Anne Sophie Enevoldsen, Erika B Gram, Per Damkier iD

Basic & Clinical Pharmacology & Toxicology · 2025

DOI: 10.1111/bcpt.70105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Anne-Johanne Andersen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Antidepressive Agents, Drug Utilization, Practice Patterns, Physicians', Pregnancy Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We evaluated trends in antidepressant use among pregnant women in Denmark from 2001 to 2023, comparing them with a matched comparison group from the general population. Data from the Danish Health Data Authority were used to assess annual antidepressant prescription redemption rates per 1000 pregnancies, with a focus on total antidepressant use, selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenaline reuptake inhibitors (SNRIs). Antidepressant use among pregnant women increased fivefold in the study period. In the comparison group, use increased 2.3‐fold. After a decline following 2011, antidepressant use among pregnant women began to rise again in 2019, driven primarily by sertraline, which accounted for 76% of prescription redemptions in 2023. Other drugs such as escitalopram, duloxetine, mirtazapine and amitriptyline showed modest increases, while the use of most other antidepressants declined or stabilized. This upward trend likely reflects the influence of updated clinical guidelines and greater clinical acceptance of antidepressant use during pregnancy. Our findings emphasize how prescribing practices are sensitive to shifts in public discourse and guideline revisions, highlighting the importance of ongoing pharmacovigilance in managing maternal mental health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsDrug UtilizationPractice Patterns, Physicians'Pregnancy ComplicationsDepressionFemaleHumansPregnancyDenmarkAdultSelective Serotonin Reuptake InhibitorsYoung AdultSerotonin and Noradrenaline Reuptake InhibitorsPharmacovigilanceDrug Prescriptions

Stichwörter der Autor:innen

antidepressantsdrug‐utilizationpopulation‐basedpregnancyprescription

Substanzen

Antidepressive AgentsSelective Serotonin Reuptake InhibitorsSerotonin and Noradrenaline Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Anne-Johanne Andersen, Per Damkier

Zitieren

APA

Andersen, A. J., Enevoldsen, K. N., Enevoldsen, A. S., Gram, E. B., & Damkier, P. (2025). Antidepressants Use Among Pregnant Women in Denmark From 2001 to 2023: A Population‐Level Drug Utilization Study. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70105

Vancouver

Andersen AJ, Enevoldsen KN, Enevoldsen AS, Gram EB, Damkier P. Antidepressants Use Among Pregnant Women in Denmark From 2001 to 2023: A Population‐Level Drug Utilization Study. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70105

BibTeX
@article{Andersen2025,
  author = {Andersen, Anne-Johanne and Enevoldsen, Kasper Nørlund and Enevoldsen, Anne Sophie and Gram, Erika B and Damkier, Per},
  title = {Antidepressants Use Among Pregnant Women in Denmark From 2001 to 2023: A Population‐Level Drug Utilization Study},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  doi = {10.1111/bcpt.70105}
}
Kostenlos starten →